Condition: Placenta Previa · Placenta Accreta Spectrum · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The main goal of this case-control study is to quantify the levels of circulating syncytiotrophoblast-derived extracellular vesicles (STBEVs) in maternal blood in a population of women with placenta previa and placenta accreta spectrum.
This description comes directly from the study's public registry record.
Chiara Tersigni · +39 3206557088 · chiara.tersigni@policlinicogemelli.it
Marianna Onori · mariannaonori@gmail.com
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario A.Gemelli IRCSS | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06867874